This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
|02/14/19||Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019|
|- Fourth quarter revenues of $1.84 billion, down 1.4% versus 2017
- Fourth quarter diluted EPS of $0.92 on a reported basis, down 49.5% from 2017 which included a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.36 on an adjusted basis excluding amortization, down 2.9% from 2017
- Full year revenues of $7.53 billion, up 1.7% from 2017
- Full year diluted EPS of $5.29 on a reported basis, down 3.8% from 2017; and $6.31 on an adjusted basis excluding amortizati... |
|02/11/19||Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories|
|Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states
SECAUCUS, N.J. and COLUMBIA, Mo., Feb. 11, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Labor... |
|01/22/19||Quest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year|
|SECAUCUS, N.J., Jan. 22, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year.
The annual survey designated Quest Diagnostics as one of only five companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry category.
"We are h... |
|01/14/19||More Adults Know Their Multidigit Wi-Fi Password Than Vital Health Information, Including Their Single-Letter Blood Type|
|Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home
Challenges Retaining and Accessing Key Medical Information are Key Drivers to This Lack of Knowledge
SECAUCUS, N.J., Jan. 14, 2019 /PRNewswire/ -- Americans have multiple numbers at their fingertips, but some of the numbers that could be most important to their health are not among them. New research released today by Quest Diagnostics (NYSE: DG... |
|01/07/19||Quest Diagnostics To Release Fourth Quarter And Full Year 2018 Financial Results On February 14|
|SECAUCUS, N.J., Jan. 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2018 results on Thursday, February 14, 2019, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
The conference call can be accessed by dialing 888-455-0391 with... |
|01/02/19||Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference|
|SECAUCUS, N.J., Jan. 2, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco. Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation... |